No Carolina / NY / Florida
Ph: 561.316.3330

New Hot Start Isothermal Mixes Boost Sensitivity, Specificity, and Speed of DNA Target Detection

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • Once the mixture is activated on heating, results can be obtained in as little as half an hour, allowing analysts to achieve highly sensitive, specific, and rapid detection of DNA targets.
  • However, a common issue with isothermal mixes is non-specific amplification — where primers bind to unintended DNA targets — because amplification often takes place at a fixed temperature which may favour non-specific primer interactions, contrary to PCR.
  • As a result, the mix enables labs to visually identify positive or negative results without the need for plate readers or fluorometric PCR instruments.

PCR Biosystems, a leading PCR reagent developer, has launched a new range of Bst polymerase reagents that offer greater sensitivity, speed, and specificity in all isothermal amplification applications. IsoFast™ Hot Start Bst Polymerase and associated ready mixes use proprietary AptaLock™ hot start technology to minimise non-specific amplification, leading to highly specific and sensitive results in as little as 30 minutes. A new colourimetric mix also enables analysts to detect results visually, vastly reducing equipment requirements. With these technologies, labs can now get reliable results more quickly, unlocking higher throughput testing.

Isothermal mixes are important in a range of isothermal amplification applications, including whole genome amplification, point-of-care assay development and testing, and strand displacement amplification for synthetic biology. However, a common issue with isothermal mixes is non-specific amplification — where primers bind to unintended DNA targets — because amplification often takes place at a fixed temperature which may favour non-specific primer interactions, contrary to PCR. Isothermal mixes can also lead to primer dimer formation, where primers associate with each other and are extended by the polymerase. To avoid these issues, users must design primers carefully, and evaluate many more primer pairs for a single target than they would for standard PCR— both of which can be extremely time-consuming and complex.

To help alleviate these concerns, PCR Biosystems’ newly launched IsoFast™ reagents use AptaLock™, a reversible hot start technology that inhibits polymerase activity below 40 °C. As such, both non-specific amplification and primer dimer formation are minimised. Once the mixture is activated on heating, results can be obtained in as little as half an hour, allowing analysts to achieve highly sensitive, specific, and rapid detection of DNA targets. High-throughput testing is also possible, as reaction plates can be set up at room temperature without any issues.

What’s more, the colour mix contains a pH-based dye that changes colour when the desired target is amplified. As a result, the mix enables labs to visually identify positive or negative results without the need for plate readers or fluorometric PCR instruments. The mix is therefore particularly beneficial for regions where point-of-care or field-testing laboratories lack adequate facilities and instrumentation.

“Existing isothermal mixes present a number of challenges for organisations looking for sensitivity, specificity, and speed in DNA detection,” stated Alex Wilson, Co-founder and Business Development Manager, PCR Biosystems. “With our new mixes, labs get greatly improved specificity and sensitivity in their amplification reactions, so they obtain highly reliable results. Our internal studies show that they can be up to 50% faster than competitor mixes on tested targets too, which can make a critical difference for diagnostic and medical labs that need results quickly.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Abu Dhabi Issues First BioTech Inventor-Class Golden Visa to Catalyze “Made-In-Abu-Dhabi IP” to Rockefeller University Inventor Dr Kambiz Shekdar, PhD

Dr Kambiz Shekdar said: "I gratefully take this opportunity as my solemn commitment to help build up the BioTech sector in Abu Dhabi with the same home-grown can-do-and-have-done record of accomplishment demonstrated by Emirati leadership, its people, and nation, and to do so collegially with the best of the best of the world's human capital across frontier technologies who, like myself, are drawn to the UAE with the thirst to pioneer and build better like only possible in the red-hot entrepreneurial climate of the UAE."

Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startups

"We celebrate the growing base of research and technological advances within the region's health and life sciences sector," said Chandra Briggman, President and CEO of Activation Capital.

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)

Investigator-Initiated Phase 2 study is being conducted at Northwestern University in cooperation with Moleculin. Trial combines WP1066 and radiation, which demonstrated both significant therapeutic response and immune "memory" in glioblastoma animal models

By using this website you agree to accept Medical Device News Magazine Privacy Policy